Crossmark

PCSK9 Inhibitor Use and Outcomes Using Concomitant Lipid-Lowering Therapies in the Veterans Health Administration

Crossref DOI link: https://doi.org/10.1016/j.ajmo.2023.100035

Published Print: 2023-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Eloso, Jessica

Awad, Asma

Zhao, Xinhua

Cunningham, Francesca E.

Zhang, Rongping

Dong, Diane

Kelley, Cathy

Glassman, Peter A.

Aspinall, Sherrie L. https://orcid.org/0000-0002-1342-6938
License Information

Text and Data Mining valid from 2023-06-01

Text and Data Mining valid from 2023-06-01

Version of Record valid from 2023-02-13
More Information

This article is maintained by: Elsevier

Article Title: PCSK9 Inhibitor Use and Outcomes Using Concomitant Lipid-Lowering Therapies in the Veterans Health Administration

Journal Title: American Journal of Medicine Open

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ajmo.2023.100035

Content Type: article

Copyright: © 2023 The Author(s). Published by Elsevier Inc.